134

studies recruiting now

as of 7 Sept 2026

966

studies registered in total

as of 7 Sept 2026

4

countries with a recruiting site

as of 7 Sept 2026

11 Mar 2026

most recent study posted

among recruiting studies

Recruiting trials

RecruitingNot applicableNCT06953115

Vagal Stimulation Therapy and Preeclampsia

Sponsor Fundación Internacional René MeyWhere Mexico (4 sites)Studying Vagal stimulation physiotherapy with trigger point release, Positional Release TherapyUpdated 2 Sept 2026

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

See all 134 recruiting studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Keep watching

Get an email when a new Preeclampsia study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Preeclampsia

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (FLT1, STOX1, CORIN).

Treatments being studied

8 approved treatments and 45 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Chlorthalidone (Chlorthalidone)Approved: Triamterene (Dyrenium)Approved: Indapamide (Cardide sr)Approved: Hydrochlorothiazide (Apo-hydro)Approved: Magnesium Sulfate (Mag sulf)Approved: Metolazone (Diulo)Approved: Spironolactone (Abbolactone)Approved: Chlorothiazide (Chlorothiazide)
Phase 3Magnesium Sulfate Anhydrous (Magnesium sulfate anhydrous component of suprep bowel prep kit)
Phase 3Retinol (Arovit)
Phase 3Atorvastatin (Cardyl)
Phase 3Misoprostol (Cytotec)
Phase 3Aspirin (8-hour bayer)
Phase 3Antithrombin Gamma
Phase 3Metformin
Phase 3Furosemide (Aluzine 20)

+ 37 more in development

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).